INSIGHTS ON DRUG DEVELOPMENT
-
![Isolated Antibody Drug Conjugates ADCs GettyImages-1438509824]( "Welcoming The \"Era Of ADCs\"")
Welcoming The "Era Of ADCs"Dr. Loretta Itri sat down to explore the promise of TRODELVY®️ and other antibody-drug conjugates as transformative treatments for a range of malignancies and intractable diseases.
-
![GettyImages-1133973085-monoclonal-antibody]( "Direct And Rapid Multi-Attribute Monitoring Of Multiple Intact mAbs")
Direct And Rapid Multi-Attribute Monitoring Of Multiple Intact mAbsWhat are the results of an innovative system for direct chip-based integration of icIEF with mass spectrometry (MS) being utilized to characterize mAbs spanning a wide pl range?
-
![GettyImages-593319838-lab-tablet-computer]( "N-Linked Glycan Analysis Of NISTmAb")
N-Linked Glycan Analysis Of NISTmAbWith the right glycan analysis kit, you can achieve a 1-minute-per-sample analysis rate, along with streamlined and high-throughput glycan analysis assay for all phases of biopharmaceutical development.
-
![GettyImages-1302254900_nasal anatomy]( "White Paper: Nasal Delivery Of Spray Dried Biologics: Opportunities And Challenges")
White Paper: Nasal Delivery Of Spray Dried Biologics: Opportunities And ChallengesExplore the potential of spray-dried nasal formulations for biologics to achieve excellent stability and targeted delivery, paving the way for innovative and effective therapeutic solutions.
-
Nitrosamine Impurities Deadline: Are Your Products Compliant?11/6/2023
The FDA nitrosamine contamination guidance set a deadline of August 1, 2025, for all drug manufacturers and market authorization holders to comply fully with the NDSRI limits set.
-
Is Industry Ready To Take A Bite Out Of Obesity?7/15/2024
What are the clinical, economic, and policy considerations for a class of drugs offering a promising treatment for obesity, and how is the industry adapting to meet demand?
-
AI-Powered Digital Pathology For Pulmonary Fibrosis Biomarker Quantification3/27/2025
Uncover how AI-driven digital pathology is revolutionizing the detection and quantification of pulmonary fibrosis markers in whole lung sections, offering new opportunities for clinical research.
-
Getting Genomic Medicines Ready For Prime Time2/5/2024
Explore the benefits of building a manufacturing process early, how research into LNPs in nucleic acid therapeutics will contribute to the development of future drugs, and more.
-
Accelerate Your R&D And QC With These 3 Key Analysis Methods5/4/2024
Learn about three key thermal analysis methods for fast and effective characterization and quality control: differential scanning calorimetry, thermogravimetric analysis, and sorption analysis.
DRUG DEVELOPMENT SOLUTIONS
-
![leica-microsystems-stellaris-5-cryo-hero]( "Cryo Confocal Light Microscope")
STELLARIS 5 Cryo Confocal Light Microscope
The STELLARIS 5 Cryo is a confocal light microscope system that helps you to target your area of interest for cryo-electron tomography (CryoET). The STELLARIS 5 Cryo gives you the precision to target reliably, while still offering superior performance you can count on and improved productivity for your experiments.
-
![adare]( "A Technology-Driven CDMO Delivering Integrated End-To-End Services")
Explore this interactive PDF with information about technologies & end-to-end integrated CDMO services provided by Adare Pharma Solutions.
-
![molecular-devices-pclamp-11-software-suite]( "Sophisticated Patch-Clamp Electrophysiology Data Acquisition And Analysis Software")
Preconfigured protocols and custom assay workflows simplify microplate data acquisition and analysis
SoftMax® Pro Software for Windows 10 is designed to provide the simplicity, flexibility and power required for advanced data analysis. It provides ready-to-run protocols, analysis algorithms, and 21 different curve fit options.
-
![THESYS™ ACS ERGO]( "Dynamic And Ergonomic Oligosynthesis Column")
These patented synthesis columns offer oligonucleotide manufacturers a system designed for efficiency and safety.
-
![GettyImages-1316775813 fill finish pharmaceutical bottles]( "Curia: Advancing Solutions For Rare Diseases")
Explore our full range of products, each backed by rigorous quality control and regulatory compliance, to find the right solution for your pharmaceutical needs.
